Reconstructive Transplant and Investigator Services

The government authority in Washington, DC requires a USA-based vendor to provide reconstructive transplant and investigator services offsite at the vendor's office premises. The buyer needs the vendor to conduct preclinical studies in animal models, as well as clinical research in human subjects or human anatomical substances. To support these operations, the vendor must advance preservation strategies by developing promising static preservation strategies, active perfusion modalities, or other technologies for clinical translation. Additionally, the vendor must develop mitigation strategies for preservation-mediated injury, specifically addressing immune activation or ischemia reperfusion injury. Eligibility remains restricted strictly to onshore USA organizations. The buyer requests proposals to establish the project budget and provides no further evaluation criteria or key dates in the solicitation details.